Application value of mixed reality in hepatectomy for hepatocellular carcinoma

Table 3 Postoperative results

Variable	Group A (n = 37)	Group B (n = 58)	P value
ALT at postoperative day 3 (U/L)	119.74 ± 29.08	135.53 ± 36.68	0.029
AST at postoperative day 3 (U/L)	106.20 ± 20.99	110.91 ± 24.99	0.343
ALB at postoperative day 3 (g/L)	33.60 ± 3.21	31.80 ± 3.51	0.014
TB at postoperative day 3 (μmol/L)	43.07 ± 8.60	44.33 ± 11.04	0.557
Perioperative complications, n (%)
Perioperative mortality	0 (0)	1 (1.72)	1.000
Hepatic failure	0 (0)	2 (3.45)	0.519
Abdominal bleeding	1 (2.70)	2 (3.45)	1.000
Bile leakage	0 (0)	2 (3.45)	0.519
Abdominal infection	1 (2.70)	3 (5.17)	0.952
Pleural effusion	2 (5.41)	6 (10.34)	0.641
Pulmonary infection	1 (2.70)	3 (5.17)	0.952
Wound infection	2 (5.41)	4 (6.90)	1.000
Total complications	7 (18.92)	23 (39.66)	0.034
CDC, n (%)			0.339
0-2	35 (94.59)	50 (86.21)
≥ 3	2 (5.41)	8 (13.79)
Hospitalization days (d)	12.05 ± 4.04	13.78 ± 4.13	0.049

ALT: Alanine aminotransferas; AST: Aspartate aminotransferase; ALB: Albumin; TB: Total bilirubin; CDC: Clavien-Dindo classification.